Hospital de Móstoles Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2005
NCT00383799
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Hospital de Móstoles. Madrid. Spain | Hospital Universitario de Móstoles

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tachycardia (Phase 4)

Tachycardia, Ventricular (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3